Figure 2.
Immune response to yeast-based immunotherapy platform expressing X (regulatory protein), S (surface), and C (core) hepatitis B virus (HBV) antigens in uninfected individuals and in those with chronic HBV infection who are taking adefovir. ELISPOT indicates enzyme-linked immunospot; IFN, interferon. Adapted from King et al.10